Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis

Thorax

Volumn 65, Issue 4, 2010, Pages 334-340

  Senoo, Tadashi ^a   Hattori, Noboru ^a   Tanimoto, Takuya ^a   Furonaka, Makoto ^a   Ishikawa, Nobuhisa ^a   Fujitaka, Kazunori ^a   Haruta, Yoshinori ^a   Murai, Hiroshi ^a   Yokoyama, Akihito ^b   Kohno, Nobuoki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b KOCHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FIBROSING ALVEOLITIS; GENETIC TRANSFECTION; LUNG ALVEOLUS CELL TYPE 2; LUNG BIOPSY; LUNG LAVAGE; MESENCHYME; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE;

EID: 77950873888     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2009.119974     Document Type: Article

References (28)

1. Katzenstein AL. Pathogenesis of "fibrosis" in interstitial pneumonia: an electron microscopic study. Hum Pathol 1985;16:1015-1024
2. Kuhn C 3rd, Boldt J, King TE Jr, et al. An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis. Am Rev Respir Dis 1989;140:1693-1703
3. Marshall BC, Sageser DS, Rao NV, et al. Alveolar epithelial cell plasminogen activator. Characterization and regulation. J Biol Chem 1990;265:8198-8204 (Pubitemid 20159000)
4. Gross TJ, Simon RH, Kelly CJ, et al. Rat alveolar epithelial cells concomitantly express plasminogen activator inhibitor-1 and urokinase. Am J Phys 1991;260:L286-95.
5. Chapman HA Jr, Stone OL, Vavrin Z. Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. Characterization of a plasminogen activator and its role in matrix degradation. J Clin Invest 1984;73:806-815 (Pubitemid 14156864)
6. Idell S, James KK, Levin EG, et al. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest 1989;84:695-705. (Pubitemid 19197006)
7. Bertozzi P, Astedt B, Zenzius L, et al. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N Engl J Med 1990;322:890-897 (Pubitemid 20108378)
8. Chapman HA, Allen CL, Stone OL. Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease. Am Rev Respir Dis 1986;133:437-443 (Pubitemid 16126278)
9. Eitzman DT, McCoy RD, Zheng X, et al. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. J Clin Invest 1996;97:232-237 (Pubitemid 26021713)
10. Zhang X, Shan P, Jiang D, et al. Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis. J Biol Chem 2004;279:10677-10684 (Pubitemid 38372680)
11. Massaro D, Massaro GD, Clerch LB. Noninvasive delivery of small inhibitory RNA and other reagents to pulmonary alveoli in mice. Am J Physiol Lung Cell Mol Physiol 2004;287:1066-1070 (Pubitemid 39391038)
12. Hattori N, Mizuno S, Yoshida Y, et al. The plasminogen activation system reduces fibrosis in the lung by a hepatocyte growth factor-dependent mechanism. Am J Pathol 2004;164:1091-1098
13. Chung MP, Monick MM, Hamzeh NY, et al. Role of repeated lung injury and genetic background in bleomycin-induced fibrosis. Am J Respir Cell Mol Biol 2003;29:375-380
14. Hattori N, Degen JL, Sisson TH, et al. Bleomycin-induced pulmonary fibrosis in fibrinogen- null mice. J Clin Invest 2000;106:1341-1350
15. Gong R, Rifai A, Tolbert EM, et al. Hepatocyte growth factor modulates matrix metalloproteinases and plasminogen activator/plasmin proteolytic pathways in progressive renal interstitial fibrosis. J Am Soc Nephrol 2003;14:3047-3060
16. Zhang LP, Takahara T, Yata Y, et al. Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells. J Hepatol 1999;31:703-711
17. Izuhara Y, Takahashi S, Nangaku M, et al. Inhibition of plasminogen activator inhibitor-1: its mechanism and effectiveness on coagulation and fibrosis. Arterioscler Thromb Vasc Biol 2008;28:672-677
18. Chaudhary NI, Schnapp A, Park JE. Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model. Am J Respir Crit Care Med 2006;173:769-776
19. Moeller A, Ask K, Warburton D, et al. The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol 2008;40:362-382
20. Wygrecka M, Markart P, Ruppert C, et al. Cellular origin of pro-coagulant and (anti)-fibrinolytic factors in bleomycin-injured lungs. Eur Respir J 2007;29:1105-1114 (Pubitemid 46895368)
21. Nishiuma T, Sisson TH, Subbotina N, et al. Localization of plasminogen activator activity within normal and injured lungs by in situ zymography. Am J Respir Cell Mol Biol 2004;31:552-558 (Pubitemid 39463404)
22. Kim KK, Kugler MC, Wolters PJ, et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci USA 2006;103:13180-13185
23. Willis BC, Liebler JM, Luby-Phelps K, et al. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am J Pathol 2005;166:1321-1332 (Pubitemid 40586504)
24. Yao HW, Xie QM, Chen JQ, et al. TGF-β1 induces alveolar epithelial to mesenchymal transition in vitro. Life Sci 2004;76:29-37.
25. Okada H, Danoff TM, Kalluri R, et al. The early role of FSP1 in epithelial-mesenchymal transformation. Am J Physiol 1997;273:563-574 (Pubitemid 127751914)
26. Miettinen PJ, Ebner R, Lopez AR, et al. TGF-β induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol 1994;127:2021-2036
27. Willis BC, Borok Z. TGF-β-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol 2007;293:525-534
28. Yoshino I, Kometani T, Shoji F, et al. Induction of epithelial- mesenchymal transition-related genes by benzo[a]pyrene in lung cancer cells. Cancer 2007;110:369-374 (Pubitemid 47121898)